Publication | Open Access

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyPathologyMolecular DiagnosticsAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyE1a2 Bcr-abl1Cancer ResearchConsensus GuidelinesHealth Sciences